Venturi mask

Last updated
Adult with air entrainment (Venturi) mask Adult with air entrainment (Venturi) mask.png
Adult with air entrainment (Venturi) mask

The venturi mask, also known as an air-entrainment mask, is a medical device to deliver a known oxygen concentration to patients on controlled oxygen therapy. [1] [2] The mask was invented by Moran Campbell at McMaster University Medical School as a replacement for intermittent oxygen treatment. Dr. Campbell was fond of quoting John Scott Haldane's description of intermittent oxygen treatment; "bringing a drowning man to the surface – occasionally". [3] [4] By contrast the venturi mask offered a constant supply of oxygen at a much more precise range of concentrations.

Contents

Use

Venturi masks are used to deliver a specified fraction of inspired oxygen (FIO2). Many masks are color-coded and have a recommended oxygen flow specified on them. [5] When used with this oxygen flow, the mask should provide the specified FIO2. Other brands of mask have a rotating attachment that controls the air entrainment window, affecting the concentration of oxygen. This system is often used with air-entrainment nebulizers to provide humidification and oxygen therapy. The total flow of gas (oxygen plus the entrained air) will be greater than the patient's peak inspiratory flow so the delivered FIO2 is independent of their respiratory pattern. [5]

A controlled FIO2 is particularly important for patients whose ventilation is dependent on hypoxic drive, [5] as may be seen in patients with chronic obstructive pulmonary disease. Administration of too much oxygen may lead to a reduction in their respiratory rate and retention of carbon dioxide, and ultimately to reduced consciousness or even death. [6]

Mechanism

The mechanism of action is variously described with reference to the venturi effect or Bernoulli's principle. [7] However, a fixed performance oxygen delivery system works on the principle of jet mixing. Where the flow of moving oxygen meets the static air, viscous shearing causes a predictable amount of the air to be dragged into the flow. [7] [8]

See also

Related Research Articles

<span class="mw-page-title-main">Hypoxia (medicine)</span> Medical condition of lack of oxygen in the tissues

Hypoxia is a condition in which the body or a region of the body is deprived of adequate oxygen supply at the tissue level. Hypoxia may be classified as either generalized, affecting the whole body, or local, affecting a region of the body. Although hypoxia is often a pathological condition, variations in arterial oxygen concentrations can be part of the normal physiology, for example, during strenuous physical exercise.

<span class="mw-page-title-main">Respiratory failure</span> Inadequate gas exchange by the respiratory system

Respiratory failure results from inadequate gas exchange by the respiratory system, meaning that the arterial oxygen, carbon dioxide, or both cannot be kept at normal levels. A drop in the oxygen carried in the blood is known as hypoxemia; a rise in arterial carbon dioxide levels is called hypercapnia. Respiratory failure is classified as either Type 1 or Type 2, based on whether there is a high carbon dioxide level, and can be acute or chronic. In clinical trials, the definition of respiratory failure usually includes increased respiratory rate, abnormal blood gases, and evidence of increased work of breathing. Respiratory failure causes an altered state of consciousness due to ischemia in the brain.

<span class="mw-page-title-main">Oxygen toxicity</span> Toxic effects of breathing oxygen at high partial pressures

Oxygen toxicity is a condition resulting from the harmful effects of breathing molecular oxygen at increased partial pressures. Severe cases can result in cell damage and death, with effects most often seen in the central nervous system, lungs, and eyes. Historically, the central nervous system condition was called the Paul Bert effect, and the pulmonary condition the Lorrain Smith effect, after the researchers who pioneered the discoveries and descriptions in the late 19th century. Oxygen toxicity is a concern for underwater divers, those on high concentrations of supplemental oxygen, and those undergoing hyperbaric oxygen therapy.

<span class="mw-page-title-main">Oxygen therapy</span> Use of oxygen as a medical treatment

Oxygen therapy, also referred to as supplemental oxygen, is the use of oxygen as medical treatment. Supplemental oxygen can also refer to the use of oxygen enriched air at altitude. Acute indications for therapy include hypoxemia, carbon monoxide toxicity and cluster headache. It may also be prophylactically given to maintain blood oxygen levels during the induction of anesthesia. Oxygen therapy is often useful in chronic hypoxemia caused by conditions such as severe COPD or cystic fibrosis. Oxygen can be delivered via nasal cannula, face mask, or endotracheal intubation at normal atmospheric pressure, or in a hyperbaric chamber. It can also be given through bypassing the airway, such as in ECMO therapy.

<span class="mw-page-title-main">Bronchoconstriction</span> Constriction of the terminal airways in the lungs

Bronchoconstriction is the constriction of the airways in the lungs due to the tightening of surrounding smooth muscle, with consequent coughing, wheezing, and shortness of breath.

<span class="mw-page-title-main">Continuous positive airway pressure</span> Form of ventilator which applies mild air pressure continuously to keep airways open

Continuous positive airway pressure (CPAP) is a form of positive airway pressure (PAP) ventilation in which a constant level of pressure greater than atmospheric pressure is continuously applied to the upper respiratory tract of a person. The application of positive pressure may be intended to prevent upper airway collapse, as occurs in obstructive sleep apnea, or to reduce the work of breathing in conditions such as acute decompensated heart failure. CPAP therapy is highly effective for managing obstructive sleep apnea. Compliance and acceptance of use of CPAP therapy can be a limiting factor, with 8% of people stopping use after the first night and 50% within the first year.

Edward James Moran Campbell, was a Canadian physician. He was the founding Chair of the Department of Medicine at McMaster Faculty of Health Sciences from 1968 to 1975. He was also the inventor of the Venturi mask.

Restrictive lung diseases are a category of extrapulmonary, pleural, or parenchymal respiratory diseases that restrict lung expansion, resulting in a decreased lung volume, an increased work of breathing, and inadequate ventilation and/or oxygenation. Pulmonary function test demonstrates a decrease in the forced vital capacity.

Williams–Campbell syndrome (WCS) is a disease of the airways where cartilage in the bronchi is defective. It is a form of congenital cystic bronchiectasis. This leads to collapse of the airways and bronchiectasis. It acts as one of the differential to allergic bronchopulmonary aspergillosis. WCS is a deficiency of the bronchial cartilage distally.

<span class="mw-page-title-main">Pulmonary function testing</span> Test to evaluate respiratory system

Pulmonary function testing (PFT) is a complete evaluation of the respiratory system including patient history, physical examinations, and tests of pulmonary function. The primary purpose of pulmonary function testing is to identify the severity of pulmonary impairment. Pulmonary function testing has diagnostic and therapeutic roles and helps clinicians answer some general questions about patients with lung disease. PFTs are normally performed by a pulmonary function technologist, respiratory therapist, respiratory physiologist, physiotherapist, pulmonologist, or general practitioner.

<span class="mw-page-title-main">Portable oxygen concentrator</span> Device used to provide oxygen therapy

A portable oxygen concentrator (POC) is a device used to provide oxygen therapy to people that require greater oxygen concentrations than the levels of ambient air. It is similar to a home oxygen concentrator (OC), but is smaller in size and more mobile. They are small enough to carry and many are now FAA-approved for use on airplanes.

Pulmonary rehabilitation, also known as respiratory rehabilitation, is an important part of the management and health maintenance of people with chronic respiratory disease who remain symptomatic or continue to have decreased function despite standard medical treatment. It is a broad therapeutic concept. It is defined by the American Thoracic Society and the European Respiratory Society as an evidence-based, multidisciplinary, and comprehensive intervention for patients with chronic respiratory diseases who are symptomatic and often have decreased daily life activities. In general, pulmonary rehabilitation refers to a series of services that are administered to patients of respiratory disease and their families, typically to attempt to improve the quality of life for the patient. Pulmonary rehabilitation may be carried out in a variety of settings, depending on the patient's needs, and may or may not include pharmacologic intervention.

<span class="mw-page-title-main">Acute exacerbation of chronic obstructive pulmonary disease</span> Medical condition

An acute exacerbation of chronic obstructive pulmonary disease, or acute exacerbations of chronic bronchitis (AECB), is a sudden worsening of chronic obstructive pulmonary disease (COPD) symptoms including shortness of breath, quantity and color of phlegm that typically lasts for several days.

In some individuals, the effect of oxygen on chronic obstructive pulmonary disease is to cause increased carbon dioxide retention,

<span class="mw-page-title-main">Chronic obstructive pulmonary disease</span> Lung disease involving long-term poor airflow

Chronic obstructive pulmonary disease (COPD) is a type of progressive lung disease characterized by long-term respiratory symptoms and airflow limitation. GOLD 2024 defined COPD as a heterogeneous lung condition characterized by chronic respiratory symptoms due to abnormalities of the airways and/or alveoli (emphysema) that cause persistent, often progressive, airflow obstruction.

<span class="mw-page-title-main">Heated humidified high-flow therapy</span> Respiratory support method

Heated humidified high-flow therapy, often simply called high flow therapy, is a type of respiratory support that delivers a flow of medical gas to a patient of up to 60 liters per minute and 100% oxygen through a large bore or high flow nasal cannula. Primarily studied in neonates, it has also been found effective in some adults to treat hypoxemia and work of breathing issues. The key components of it are a gas blender, heated humidifier, heated circuit, and cannula.

Medical gas therapy is a treatment involving the administration of various gases. It has been used in medicine since the use of oxygen therapy. Most of these gases are drugs, including oxygen. Many other gases, collectively known as factitious airs, were explored for medicinal value in the late eighteenth century. In addition to oxygen, medical gases include nitric oxide (NO), and helium-O2 mixtures (Heliox). Careful considerations and close monitoring needed when medical gases are in use. For the purpose of this article only gas mixtures are described.

Physiotherapists treating patients following uncomplicated coronary artery bypass surgery surgery continue to use interventions such as deep breathing exercises that are not supported by best available evidence. Standardised guidelines may be required to better match clinical practice with current literature.

Professor Richard M. Leach FRCP is a British Consultant Physician and Professor at Guy's and St Thomas’ NHS Foundation Trust, who is accredited in general, respiratory and critical care medicine. He has pioneered multiple respiratory care techniques and been instrumental in the development of numerous NICE guidelines relating to acute medicine. It has been reported that he led the care of British prime minister Boris Johnson during the 2020 COVID-19 pandemic.

<span class="mw-page-title-main">Glossary of breathing apparatus terminology</span> Definitions of technical terms used in connection with breathing apparatus

A breathing apparatus or breathing set is equipment which allows a person to breathe in a hostile environment where breathing would otherwise be impossible, difficult, harmful, or hazardous, or assists a person to breathe. A respirator, medical ventilator, or resuscitator may also be considered to be breathing apparatus. Equipment that supplies or recycles breathing gas other than ambient air in a space used by several people is usually referred to as being part of a life-support system, and a life-support system for one person may include breathing apparatus, when the breathing gas is specifically supplied to the user rather than to the enclosure in which the user is the occupant.

References

  1. Use of a reservoir nasal cannula in hospitalized patients with refractory hypoxemia; Sheehan, JC, O'Donohue, WJ; Chest. 1996; 110:s1.
  2. Bateman NT, Leach RM (1998). "ABC of oxygen. Acute oxygen therapy". BMJ. 317 (7161): 798–801. doi:10.1136/bmj.317.7161.798. PMC   1113909 . PMID   9740573.
  3. Gibson, G. J. (2004-09-01). "Moran Campbell and clinical science". Thorax. 59 (9): 737–740. doi:10.1136/thx.2004.032219. ISSN   0040-6376. PMC   1747134 . PMID   15333847.
  4. Sekhar, KC; Rao, SSC Chakra (2014). "John Scott Haldane: The father of oxygen therapy". Indian Journal of Anaesthesia. 58 (3): 350–352. doi: 10.4103/0019-5049.135087 . ISSN   0019-5049. PMC   4091013 . PMID   25024490.
  5. 1 2 3 Al-Shaikh, Baha; Stacey, Simon (2013). "Masks and oxygen delivery devices". Essentials of Anaesthetic Equipment (4th ed.). Elsevier. pp. 99–110. doi:10.1016/B978-0-7020-4954-5.00006-1. ISBN   9780702049545 . Retrieved 3 October 2022.
  6. Young, IH (2007). "Revisiting oxygen therapy in patients with exacerbation of chronic obstructive pulmonary disease". The Medical Journal of Australia. 186 (5): 239. doi:10.5694/j.1326-5377.2007.tb00880.x. PMID   17391085. S2CID   27365725.
  7. 1 2 Kittredge P (1983). "Neither Venturi nor Bernoulli". Lancet. 1 (8317): 182. doi:10.1016/s0140-6736(83)92779-4. PMID   6130219. S2CID   10964089.
  8. Scacci R (1979). "Air entrainment masks: jet mixing is how they work; the Venturi and Bernoulli principles are how they don't". Respir. Care. 24: 928–931.